Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standards of Care?

Abstract

Objective In the last years, there has been increasing evidence of cardiac involvement in spinal muscular atrophy (SMA). Autonomic dysfunction has been reported in animal models and in several patients with types I and III SMA, these findings raising the question whether heart rate should be routinely investigated in all SMA patients. The aim of our study was to detect possible signs of autonomic dysfunction and, more generally, of cardiac involvement in types II and III SMA.

Patients and Methods We retrospectively reviewed 24-hour electrocardiography (ECG) in 157 types II and III SMA patients (age range, 2–74 years). Of them, 82 also had echocardiography.

Results None of the patients had signs of bradycardia, atrial fibrillation, or the other previously reported rhythm disturbances regardless of the age at examination or the type of SMA. Echocardiography was also normal. There were no signs of congenital cardiac defects with the exception of one patient with a history of ventricular septal defects.

Conclusions Our results suggest that cardiac abnormalities are not common in type II and type III SMA. These findings provide no evidence to support a more accurate cardiac surveillance or changes in the existing standards of care.

Keywords

SMA - cardiac function - standard of care

• References

• 1 Menke LA, Poll-The BT, Clur SA , et al. Congenital heart defects in spinal muscular atrophy type I: a clinical report of two siblings and a review of the literature. Am J Med Genet A 2008; 146A (6) 740-744
• 2 Rudnik-Schöneborn S, Heller R, Berg C , et al. Congenital heart disease is a feature of severe infantile spinal muscular atrophy. J Med Genet 2008; 45 (10) 635-638
• 3 Bach JR, Saltstein K, Sinquee D, Weaver B, Komaroff E. Long-term survival in Werdnig-Hoffmann disease. Am J Phys Med Rehabil 2007; 86 (5) 339-345 , quiz 346–348, 379
• 4 Bach JR. Medical considerations of long-term survival of Werdnig-Hoffmann disease. Am J Phys Med Rehabil 2007; 86 (5) 349-355
• 5 Heier CR, Satta R, Lutz C, DiDonato CJ. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet 2010; 19 (20) 3906-3918
• 6 Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL. Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet 2010; 19 (20) 4059-4071
• 7 Takahashi N, Shimada T, Ishibashi Y , et al. Cardiac involvement in Kugelberg-Welander disease: a case report and review. Am J Med Sci 2006; 332 (6) 354-356
• 8 Elkohen M, Vaksmann G, Elkohen MR, Francart C, Foucher C, Rey C. Cardiac involvement in Kugelberg-Welander disease. A prospective study of 8 cases [in French]. Arch Mal Coeur Vaiss 1996; 89 (5) 611-617
• 9 Palladino A, Passamano L, Taglia A , et al. Cardiac involvement in patients with spinal muscular atrophies. Acta Myol 2011; 30 (3) 175-178
• 10 Bushby K, Finkel R, Birnkrant DJ , et al; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9 (1) 77-93
• 11 Wang CH, Finkel RS, Bertini ES , et al; Participants of the International Conference on SMA Standard of Care. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007; 22 (8) 1027-1049
• 12 Wang CH, Lunn MR. Spinal muscular atrophy: advances in research and consensus on care of patients. Curr Treat Options Neurol 2008; 10 (6) 420-428
• 13 Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol 2012; 11 (5) 443-452
• 14 Kinali M, Mercuri E, Main M , et al. Pilot trial of albuterol in spinal muscular atrophy. Neurology 2002; 59 (4) 609-610
• 15 Pane M, Staccioli S, Messina S , et al. Daily salbutamol in young patients with SMA type II. Neuromuscul Disord 2008; 18 (7) 536-540
• 16 Tiziano FD, Lomastro R, Pinto AM , et al. Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. J Med Genet 2010; 47 (12) 856-858
• 17 Tiziano FD, Lomastro R, Di Pietro L , et al. Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study. Eur J Hum Genet 2013; 21 (6) 630-636
• 18 Kadish AH, Buxton AE, Kennedy HL , et al. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography. A report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography). J Am Coll Cardiol 2001; 38 (7) 2091-2100
• 19 Southall DP, Johnston F, Shinebourne EA, Johnston PG. 24-hour electrocardiographic study of heart rate and rhythm patterns in population of healthy children. Br Heart J 1981; 45 (3) 281-291
• 20 Quiñones MA, Douglas PS, Foster E , et al; American College of Cardiology; American Heart Association; American College of Physicians-American Society of Internal Medicine; American Society of Echocardiography; Society of Cardiovascular Anesthesiologists; Society of Pediatric Echocardiography. ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. J Am Coll Cardiol 2003; 41 (4) 687-708
• 21 Kampmann C, Wiethoff CM, Wenzel A , et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000; 83 (6) 667-672